Eikon Therapeutics’ Post

A new future for male contraceptives? Nadja Mannowetz is a notable figure in the field of reproductive biology and contraception research. She is the Chief Scientific Officer and Co-Founder of YourChoice Therapeutics, a company that is pioneering the development of novel non-hormonal contraceptive products. The company is working on a reversible male contraceptive drug, YCT-529, which prevents the production of new sperm. YourChoice Therapeutics aims to have a contraceptive ready to market by 2025 and is seeking venture capital funding to continue its research and development In her research, Mannowetz has focused on sperm physiology and sperm-egg interactions. Alongside Polina Lishko she has discovered that natural compounds such as lupeol and pristimerin can block human sperm's ability to penetrate the egg's protective shield, the zona pellucida. These compounds act on the sperm surface, maintaining the cells in a state unable to initiate the final act required for fertilization, making them promising candidates for effective, non-toxic, and non-hormonal contraceptives Mannowetz's work represents a significant shift in contraceptive research, moving away from hormone-based drugs towards non-hormonal alternatives that could potentially have fewer side effects and be more universally acceptable. Her contributions to the field could lead to more sustainable and inclusive contraceptive options in the future University of California, Berkeley #contraceptive #innovation #biotech #lifesciences #mews #womanentrepreneur #womaninbusiness

Every antibody that Bethyl sells is manufactured in-house, so we pride ourselves in our manufacturing processes. Meet Crystal Billings and Madison Blice, two of the women who help coordinate these manufacturing efforts. Check out their features to learn more about why they love working at Fortis Life Sciences. #WomensHistoryMonth #WomensHistoryMonth2024 #seeher #womeninscience #womeninstem #researchantibodies #antibodyresearch #monoclonalantibodies #polyclonalantibodies #manufacturing #logistics

Break through barriers with Masternomics! 🌟 Overcome challenges and unlock your highest potential with the expert guidance and support provided by our transformative programs. Let's conquer obstacles together and pave the way to your success. #Masternomics #BreakthroughBarriers #OvercomeChallenges #HighestPotential #ExpertGuidance #TransformativePrograms #SuccessJourney #ConquerObstacles #PersonalGrowth

With only two weeks to go, it's time to get acquainted with the impressive full line up for the INCLUSION: Diversity, Equity & Inclusion Summit. Held September 20 at the Boston Convention and Exhibition Center, part of Biotech Week Boston. With access to the BioProcess International and Cell & Gene Therapy exhibits and our BWB Festival Party. 📍 Boston Convention and Exhibition Center 🗓️ 20th September 2023 💲 Discounted rates for group bookings & NPOs! ⚡ Part of Biotech Week Boston ⚡ Additional access to multiple biotech event exhibits* 🌐 bit.ly/3JVQY3W This is your chance to get connected with the pioneers who are leading the way for meaningful change in Biotech and STEM. Rub shoulders and engage in innovative discussions with the trailblazers of inclusion, and leave with practical strategies and best practices to drive positive change in your organization. Hear from: Azurii Collier - Director, President & Board Chair, Abbvie, Women in Bio Karen Lewis - Chief People Officer, Apellis Pharmaceuticals Chaunté Lowe - American Record Holder, TEDx Speaker, Olympic Medalist Kenn Turner - President and Chief Executive Officer, Massachusetts Life Sciences Center Michelle Laws - Chief Experience Officer, North Carolina Medical Society Tamicka James - Senior Director and Head of Diversity and Inclusion, US Commercial, Medical, Government Affairs, Genentech Quinnie Wong - Diversity, Equity and Inclusion (DEI) Director, Pfizer You'll learn how to create impact in the biotechnology space, and how to use diversity for innovation and advancement in the industry. Leave with key knowledge on cultivating a winning culture within an organization, with strategies to advance leaders and retain top talent. With only two weeks left to book, it's time to secure your spot today and get networking with our best and brightest! bit.ly/3JVQY3W #Diversity #Equity #Inclusion #InclusionSummit #DiversityEquityInclusionSummit #BiotechWeekBoston #BWB #Biotech #Lifesciences #Conference #BioPharma #Event #BiotechEvent #LifeSciencesEvent #BostonEvent #BiotechBoston #BioProcessing #InformaConnect #Informa

Every day we are in contact with chemicals ⚗ in clothes, food, cosmetics, pharmaceutical products, and even in the water we drink! Therefore, it is important to know that the chemicals we are all exposed to are safe. Chemicals are traditionally tested on animals 🐰 🐭 , however, Raffaella Corvi at EU Science, Research and Innovation studies a range of innovative alternative approaches. From methods that use human cells to methods that are computer-based and can accurately model human biology. These alternative methods are often more reliable and effective than animal testing. Besides the positive impact on human health, this research also protects the environment 🌍 and save laboratory animals! Raffaella Corvi Maurice Whelan, Elisabet Berggren, Ciarán NICHOLL, Stéphanie Laduron #science4policy #innovation #EUScientists #womeninscience #ECVAM

I had the pleasure of meeting Emily Leproust, Founder & CEO of Twist Bioscience last year and she is an amazing women that founded an equally amazing company! Check out the latest episode of @Oracle Life Sciences' Five3One series is now live! Listen to the CEO of @Twist Bioscience to learn how high-throughput synthesis and sequencing of #DNA can transform #clinicalresearch and improve the patient experience. https://lnkd.in/djiHQZWt

In recognition of International Women's Day, we've assembled a unique top 10 list. These entries represent the top 10 VC rounds in biotech from 2023, with women CEOs leading the charge. As promising as this progress is, we still have a long way to go in our industry. Looking back at the top 50 VC rounds of 2023, only 20% were led by women. 0% in the top 10. According to Biotechnology Innovation Organization's 2022 DEI report, only 20% of CEOs in the biotech industry are women. Additionally, only 34% of women are on executive teams, despite women making up 49% of the total workforce. Link to full report here: https://lnkd.in/deaSEaDD CARGO Therapeutics |Gina Simmons Chapman | $200M (A) Upstream Bio | Samantha Truex | $200M (B) Avalyn Pharma Inc. | Lyn Baranowski | $175M (C) Bicara Therapeutics | Claire Mazumdar | $165M & 108M (B&C) Carmot Therapeutics, Inc. | Heather Turner | $150M (E) Harpoon Therapeutics | Julie Eastland | $150M (PIPE) Abdera Therapeutics | Lori Lyons-Williams | $142M (B) Chroma Medicine | Catherine Stehman-Breen | $135M (B) Alltrna | Michelle Werner | $109M (B) HighTide Therapeutics| Liping Liu | $107M (C)

🔬✨ Journeying through the helix of leadership at Biolytic... I've been blessed to navigate the intricate pathways of leading a pioneering company in synthetic DNA and RNA synthesis. But here's a lesson that stands out—much like how every nucleotide sequence matters in DNA, every word and intention matters in communication. 🧬🗣 One of the most profound realizations I've had is the immense value of tailored communication. Before conveying a message, I’ve learned to ask: "Who is my audience?" and "What outcome do I envision?" It’s not just about what we say, but how we say it and to whom we say it. The content is just as important as the delivery. So, as we delve deeper into the ever-evolving world of biotechnology, let's also remember the importance of refining our 'communication code.' Tailoring our messages ensures that our intentions are clear, our audience feels understood, and our collective goals are met. 🌐🌟 #CEO #journey #myjourney #LeadershipJourney #InnovationLegacy #EmbracingChange #ForwardTogether #biotech #culture #employees #customervalue #innovation #leadership 

My next book!

As we mark International Women's Day, it's crucial to spotlight the remarkable women shaping the future of the biotech and pharma industries. These pioneers exemplify leadership, innovation, and resilience, pushing boundaries and setting new benchmarks. 🔬 Dr. Janet Woodcock - With a career that began in 1986 at the FDA, Dr. Woodcock has risen through the ranks to become a cornerstone of drug evaluation and research. Her commitment to drug safety and patient feedback has profoundly influenced treatment approvals, showcasing her dedication to advancing healthcare. 💡 Emma Walmsley - As the first woman to lead a top 10 pharmaceutical company, Walmsley's leadership at GlaxoSmithKline has been transformative. Her strategic vision and push for diversity within the company highlight the critical role women play in leading global corporations towards innovation and success. 🧬 Jennifer Doudna & Emmanuelle Charpentier - This dynamic duo's discovery of CRISPR-Cas9, a revolutionary gene engineering tool, has opened new horizons in medical research. Their work, which earned them the Nobel Prize in Chemistry, is a testament to the groundbreaking contributions women are making in the field of life sciences. These leaders, among countless others, have carved paths of excellence in their fields, challenging the status quo and advancing the frontiers of medicine and science. As we celebrate International Women's Day, let us honor their achievements and the profound legacy they continue to build within the biotech and pharma industries. #InternationalWomensDay #Biotech #Pharma #Leadership #Innovation Sources - proclinical.com & pharmamanufacturing.com